Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options.
Eur Arch Psychiatry Clin Neurosci. 2023 Oct;273(7):1477-1487. doi: 10.1007/s00406-022-01532-3. Epub 2022 Dec 27.
Eur Arch Psychiatry Clin Neurosci. 2023.
PMID: 36574032
Review.
Chronic administration of XBD173 ameliorates cognitive deficits and neuropathology via 18 kDa translocator protein (TSPO) in a mouse model of Alzheimer's disease.
Pradhan AK, Neumüller T, Klug C, Fuchs S, Schlegel M, Ballmann M, Tartler KJ, Pianos A, Garcia MS, Liere P, Schumacher M, Kreuzer M, Rupprecht R, Rammes G.
Pradhan AK, et al.
Transl Psychiatry. 2023 Oct 27;13(1):332. doi: 10.1038/s41398-023-02630-z.
Transl Psychiatry. 2023.
PMID: 37891168
Free PMC article.
Item in Clipboard
The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders-a double-blind, randomized, placebo-controlled proof-of-concept study.
Brunner LM, Riebel M, Wein S, Koller M, Zeman F, Huppertz G, Emmer T, Eberhardt Y, Schwarzbach J, Rupprecht R, Nothdurfter C.
Brunner LM, et al.
Trials. 2024 Apr 22;25(1):274. doi: 10.1186/s13063-024-08120-x.
Trials. 2024.
PMID: 38650030
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite